Perioperative Β-Blockade in Patients Undergoing Noncardiac Surgery: A Review of the Major Randomized Clinical Trials

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 5, 2009, Pages 684-693

  Leibowitz, Andrew B ^a   Porter, Steven B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

blockers; noncardiac surgery; perioperative blockade; risk stratification

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL; PLACEBO;

AORTA ANEURYSM; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; HUMAN; MEDICAID; MEDICARE; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; VASCULAR SURGERY;

ADRENERGIC BETA-ANTAGONISTS; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70349575739     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.01.017     Document Type: Review

References (22)

1. POISE Study Group. Effects of extended release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomized controlled trial. Lancet 31 (2008) 1839-1847
2. Fleisher L.A., and Poldermans D. Perioperative β-blockade: Where do we go from here?. Lancet 31 (2008) 1813-1814
3. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50 (2007) e159-e241
4. McGory M.L., Maggard M.A., and Ko C.Y. A meta-analysis of perioperative beta-blockade: What is the actual risk reduction. Surgery 138 (2005) 171-179
5. Wiesbauer F., Schlager O., Domanovits H., et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: A systematic review and meta-analysis. Anesth Analg 104 (2007) 27-41
6. Schouten O., Shaw L.J., Boersma E., et al. A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coron Artery Dis 17 (2006) 173-179
7. Beattie W.S., Wijeysundera D.N., Karkouti K., et al. Does tight heart rate control improve beta-blocker efficacy?. An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 106 (2008) 1039-1048
8. London M.J. Beta-blockade in the perioperative period: Where do we stand after all the trials?. Semin Cardiothorac Vasc Anesth 10 (2006) 17-23
9. Schouten O., Bax J.J., Dunkelgrun M., et al. Pro: Beta-blockers are indicated for patients at risk for cardiac complication undergoing noncardiac surgery. Anesth Analg 104 (2007) 8-10
10. London M.J. Con: Beta-blockers are indicated for patients at risk for cardiac complication undergoing noncardiac surgery. Anesth Analg 104 (2007) 11-14
11. Mangano D.T., Layug E.L., Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Eng J Med 335 (1996) 1713-1720
12. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
13. Poldermans D., Boersma E., Bax J.J., et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 22 (2001) 1353-1358
14. POBBLE Trial Investigators. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
15. Yang H., Raymer K., Butler R., et al. The effects of perioperative beta-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152 (2006) 983-990
16. Juul A.B., Wetterslev J., Gluud C., et al. Effect of perioperative beta-blockade in patients with diabetes undergoing major non-cardiac surgery: Randomised placebo controlled, blinded multicentre trial. BMJ 332 (2006) 1482-1489
17. Lee T.H., Marcantonio E.R., Mangione C.M., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
18. Lindenauer P.K., Pekow P., Wang K., et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
19. Bangalore S., Wetterslev J., Pranash S., et al. Perioperative beta-blockers in patients have non-cardiac surgery: A meta-analysis. Lancet 372 (2008) 1962-1976
20. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107 (2003) 149-158
21. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
22. Poldermans D., Bax J.J., Schouten O., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate risk patients receiving beta-blocker therapy with tight heart rate control. J Am Coll Cardiol 48 (2006) 964-9969